MENU
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioXcel Therapeutics (BTAI) Ownership - Who owns BioXcel Therapeutics?
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
55.17M
P/E Ratio
N/A
Total Cash
17.44M
Projected Growth
N/A
Total Debt
108.94M
Revenue
868K
Risk (Beta)
-0.19
Dividend Yield
N/A
Total Cash/Share
1.20
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
Fundamentals
BTAI
Capitalization
55.2M
P/E Ratio
N/A
Risk (Beta)
-0.19
Dividend Yield
N/A
Total Cash
17.4M
Total Cash/Share
1.20
Total Debt
109M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
868K
ROE
N/A
Book Value
-107.67M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-11.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
60K
Current Ratio
0.76
Current Revenue Per Employee
3243.24
Dividends Per Share - Security
N/A
EBITDA
-34.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
10.83
Revenue To Assets
-111.70
Shares Held By Institutions
1.33M
Shares Outstanding - Current
14.6M
Total Liabilities
133M
Total Volume MTD
N/A
Value
-1
Gain YTD
-36.648
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com